Bone sarcomas: ESMO–PaedCan–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
PG Casali, S Bielack, N Abecassis, HT Aro… - Annals of …, 2018 - annalsofoncology.org
… Risk factors for the occurrence of OS include previous radiotherapy (RT), Paget disease
of bone and germline genetic abnormalities associated with Li–Fraumeni syndrome, Werner …
of bone and germline genetic abnormalities associated with Li–Fraumeni syndrome, Werner …
High-grade glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
R Stupp, M Brada, MJ Van Den Bent… - Annals of …, 2014 - annalsofoncology.org
… Exposure to ionising irradiation has been associated with increased risk of development
of glioma, while association with the use of cell phones could not be confirmed in …
of glioma, while association with the use of cell phones could not be confirmed in …
Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of …
JD Rizzo, AE Lichtin, SH Woolf… - Blood, The Journal …, 2002 - ashpublications.org
… as the inhibitory effect of tumor necrosis factor that accounts for … achieved solely through
tumor reduction before considering … for chemotherapy-associated anemia if clinically indicated. …
tumor reduction before considering … for chemotherapy-associated anemia if clinically indicated. …
Magnetic resonance imaging of tumor-associated macrophages: clinical translation
… We found that tumor MRI enhancement at 24 hours after iv injection of … tumors to TAM-modulating
immunotherapies and help to monitor these immunotherapies in clinical practice…
immunotherapies and help to monitor these immunotherapies in clinical practice…
[HTML][HTML] Prognostic immunohistologic markers in human tumors: why are so few used in clinical practice?
Y Natkunam, DY Mason - Laboratory investigation, 2006 - Elsevier
… Similarly, it has been reported that survival differences associated with … tumor behavior is
related to the strength of its predictive power and the available treatment. A marker associated …
related to the strength of its predictive power and the available treatment. A marker associated …
Intracranial tumor surgery in patients> 70 years of age: is clinical practice worthwhile or futile?
SG Rogne, A Konglund, TR Meling… - Acta neurologica …, 2009 - Wiley Online Library
… resection, as opposed to biopsy, were significantly associated with survival. Gender, age and
… Conclusions – Surgery for intracranial tumors in selected elderly patients is worthwhile, not …
… Conclusions – Surgery for intracranial tumors in selected elderly patients is worthwhile, not …
… chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology clinical practice guideline
AA Wright, K Bohlke, DK Armstrong… - Journal of Clinical …, 2016 - ascopubs.org
… Clinical factors that were associated with suboptimal cytoreduction were age ≥ 60 … tumors,
mortality was lower with endometrioid tumors and higher with clear cell and mucinous tumors)…
mortality was lower with endometrioid tumors and higher with clear cell and mucinous tumors)…
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
RV Lalla, J Bowen, A Barasch, L Elting, J Epstein… - Cancer, 2014 - Wiley Online Library
… Furthermore, the use of granulocyte–colony-stimulating factor during H&NRT has been
associated with reduced local tumor control.33 Due to inadequate and/or conflicting evidence, no …
associated with reduced local tumor control.33 Due to inadequate and/or conflicting evidence, no …
American Society of Clinical Oncology 2008 clinical practice guideline update: use of chemotherapy and radiation therapy protectants
ML Hensley, KL Hagerty, T Kewalramani… - Journal of clinical …, 2009 - ascopubs.org
… for prophylaxis against severe mucositis associated with hematopoietic stem-cell … of tumor
protection, the use of dexrazoxane in the adjuvant setting should be used only in the clinical …
protection, the use of dexrazoxane in the adjuvant setting should be used only in the clinical …
2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer
… of cancer-associated thrombosis have also expanded with clinical trials that have compared
direct oral anticoagulants and low-molecular-weight heparin (LMWH) in patients with cancer…
direct oral anticoagulants and low-molecular-weight heparin (LMWH) in patients with cancer…